QUIZ 1 ANSWERS
Question 1. Patients with pheochromocytoma should avoid which of the following classes of drugs due
to the possibility of developing hypertensive crisis?
Expectorants
CORRECT Beta 2 agonists
Antitussives
Antihistamines
Question 2. Harold, a forty-two-year-old African American, has moderate persistent asthma. Which
of the following asthma medications should he use cautiously, if at all?
Betamethasone, an inhaled corticosteroid
CORRECT Salmeterol, an inhaled long-acting beta-agonist
Albuterol, a short-acting beta-agonist
Montelukast, a leukotriene modifier
Question 3. Patients with allergic rhinitis may benefit from a prescription of:
Fluticasone (Flonase)
Cetirizine (Zyrtec)
OTC cromolyn nasal spray (Nasalcrom)
CORRECT Any of the above
Question 4. Howard is a seventy-two-year-old male who occasionally takes diphenhydramine for his
seasonal allergies. Monitoring for this patient taking diphenhydramine would include assessing for:
, CORRECT Urinary retention
Cardiac output
Peripheral edema
Skin for rash
Question 5. Montelukast (Singulair) may be prescribed for:
A six-year-old with exercise-induced asthma.
CORRECT A two-year-old with moderate persistent asthma.
An eighteen-month-old with seasonal allergic rhinitis.
None of the above; montelukast is not approved for use in children.
Question 6. Christy has exercise and mild persistent asthma and is prescribed two puffs of albuterol
fifteen minutes before exercise and as needed for wheezing. One puff per day of beclomethasone (Qvar)
is also prescribed. Teaching regarding her inhalers includes which one of the following?
She should use one to two puffs of albuterol per day to prevent an attack, with
no more than eight puffs per day.
CORRECT Beclomethasone needs to be used every day to treat her asthma.
She should report any systemic side effects she is experiencing, such as weight
gain.
She should use the albuterol MDI immediately after her corticosteroid MDI to
facilitate bronchodilation.
Question 7. Monitoring a patient with persistent asthma includes:
Monitoring how frequently the patient has a upper respiratory infection during
treatment
Monthly in-office spirometry testing